Lutz Robert Matthew 4
4 · Strongbridge Biopharma plc · Filed Jan 8, 2021
Insider Transaction Report
Form 4
Lutz Robert Matthew
Chief Financial Officer
Transactions
- Award
Ordinary Shares
2021-01-07+147,500→ 188,311 total
Footnotes (1)
- [F1]Represents a grant of restricted stock units, which vest in full on January 7, 2023, provided the Reporting Person is employed by the Issuer on such date. Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.